4.7 Editorial Material

A dataset of non-pharmaceutical interventions on SARS-CoV-2 in Europe

Journal

SCIENTIFIC DATA
Volume 9, Issue 1, Pages -

Publisher

NATURE PORTFOLIO
DOI: 10.1038/s41597-022-01175-y

Keywords

-

Funding

  1. EPSRC Centre for Doctoral Training in Autonomous Intelligent Machines and Systems [EP/S024050/1]
  2. EA Funds programme
  3. Oxford University
  4. DeepMind
  5. Open Philanthropy
  6. U.K. BBSRC [BB/T008784/1]
  7. Augustinus Foundation
  8. Knud HOjgaard Foundation
  9. William Demant Foundation
  10. Kai Lange and Gunhild Kai Lange Foundation
  11. Aage and Johanne Louis-Hansen Foundation
  12. UKRI Centre for Doctoral Training in Interactive Artificial Intelligence [EP/S022937/1]
  13. Boehringer Ingelheim Fonds
  14. U.K. Medical Research Council (MRC), under the MRC/FCDO Concordat agreement [MR/R015600/1]
  15. U.K. Foreign, Commonwealth and Development Office (FCDO), under the MRC/FCDO Concordat agreement [MR/R015600/1]
  16. MRC Centre for Global Infectious Disease Analysis
  17. European Union
  18. Community Jameel
  19. EPSRC [EP/V002910/1]
  20. Imperial College COVID-19 Research Fund
  21. Cancer Research UK
  22. UK Research and Innovation [MR/V038109/1]
  23. Academy of Medical Sciences Springboard Award [SBF004/1080]
  24. MRC 33 [MR/R015600/1]
  25. BMGF [OPP1197730]
  26. Imperial College Healthcare NHS Trust- BRC [RDA02]
  27. Novo Nordisk Young Investigator Award [NNF20OC0059309]
  28. NIHR Health Protection Research Unit in Modelling Methodology
  29. BBSRC [BB/T008784/1] Funding Source: UKRI
  30. EPSRC [EP/S022937/1] Funding Source: UKRI
  31. Bill and Melinda Gates Foundation [OPP1197730] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

This paper introduces a new dataset that records NPIs in 114 regions of 7 European countries from August 1, 2020 to January 9, 2021. The dataset has been extensively validated and has the potential to disentangle the effectiveness of NPIs and compare the impact of interventions across different phases of the pandemic.
During the second half of 2020, many European governments responded to the resurging transmission of SARS-CoV-2 with wide-ranging non-pharmaceutical interventions (NPIs). These efforts were often highly targeted at the regional level and included fine-grained NPIs. This paper describes a new dataset designed for the accurate recording of NPIs in Europe's second wave to allow precise modelling of NPI effectiveness. The dataset includes interventions from 114 regions in 7 European countries during the period from the 1st August 2020 to the 9th January 2021. The paper includes NPI definitions tailored to the second wave following an exploratory data collection. Each entry has been extensively validated by semi-independent double entry, comparison with existing datasets, and, when necessary, discussion with local epidemiologists. The dataset has considerable potential for use in disentangling the effectiveness of NPIs and comparing the impact of interventions across different phases of the pandemic.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available